New scan could improve detection of Children's cancer
NCT ID NCT07111117
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 35 times
Summary
This study tests a new imaging method called 18F-MFBG PET/CT to see if it works as well as or better than the current standard scan (123I-MIBG) for children with neuroblastoma, a type of nerve cancer. About 30 children with relapsed or hard-to-treat neuroblastoma will receive both scans to compare how well they detect tumors. The goal is to improve diagnosis and guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gustave Roussy
Villejuif, 94805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Armand Trousseau
Paris, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Curie
Paris, 75005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.